½ÃÀ庸°í¼­
»óǰÄÚµå
1618820

¼¼°èÀÇ PTA dz¼± Ä«Å×ÅÍ ½ÃÀå : ¼ÒÀ纰, À¯Åë ä³Îº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

PTA Balloon Catheter Market by Matrerial (Nylon, Polyurethane), Distribution Channel (Offline, Online), Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 182 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

PTA dz¼± Ä«Å×ÅÍ ½ÃÀåÀº 2023³â¿¡ 28¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 30¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 6.91%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 45¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

PTA(°æÇÇ °æ°ü Ç÷°ü ¼ºÇü¼ú) dz¼± Ä«Å×ÅÍ ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ¿¡´Â ¼öÃà µÈ Ç÷°üÀ» È®ÀåÇϰųª Ç÷·ù Áõ°¡¸¦ À§ÇØ Ç÷°üÀ» ¿­µµ·Ï ¼³°èµÈ ÀåÄ¡°¡ Æ÷ÇԵǸç ÀϹÝÀûÀ¸·Î ¸»ÃÊ µ¿¸Æ Áúȯ(PAD)ÀÇ Ä¡·á¿¡ »ç¿ëµË´Ï´Ù. PTA dz¼± Ä«Å×ÅÍÀÇ Çʿ伺Àº Ç÷°ü ÇÕº´ÁõÀ» ÀÏÀ¸Å°´Â ½ÉÇ÷°ü Áúȯ Áõ°¡, ºñ¸¸ ¹× ³ëÈ­·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ÀÌ Ä«Å×ÅÍ´Â ÁÖ·Î º´¿ø°ú ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) µî ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ ÀÀ¿ëµÇ°í ÀÖÀ¸¸ç, ÃÖÁ¾ ¿ëµµ´Â ½ÉÀ庴Çаú ¸»ÃÊ Ç÷°ü ÀÎÅͺ¥¼ÇÀ» Àü¹®À¸·Î ÇÏ´Â ÀÇ·á Á¦°øÀÚ¿¡±îÁö ÆÛÁ® ÀÖ½À´Ï´Ù. ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ´Â °ÍÀº ±â¼úÀÇ Áøº¸, ÇコÄɾî ÁöÃâ Áõ°¡, Àúħ½À ¼ö±â¿¡ ´ëÇÑ ¼ö¿äÀÇ ³ô¾ÆÁüÀÔ´Ï´Ù. ÄÄÇöóÀÌ¾ð½º¿Í °¡¼Ó¼ºÀ» Çâ»ó½ÃŲ Ä«Å×ÅÍ ¼³°è Çõ½Å, ÁÖ¿ä ½ÃÀå ±â¾÷ ¹× ÀÇ·á±â°üÀÇ Àü·«Àû Á¦ÈÞ, »ýȰ ½À°üº´ÀÇ À¯º´·ü Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ºñÁî´Ï½º ±âȸ´Â °Ç°­ °ü¸® ÀÎÇÁ¶ó°¡ Á¤ºñµÇ¾î ¹Ì°³Ã´ ȯÀÚÃþÀÌ Á¸ÀçÇÏ´Â ½ÅÈï±¹¿¡ ÀÖ½À´Ï´Ù. º¸´Ù ¶Ù¾î³­ ¼º´ÉÀ» °®Ãá Â÷¼¼´ë dz¼± Ä«Å×ÅÍ °³¹ß¿¡ ÁßÁ¡À» µÐ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÔÀ¸·Î½á È®ÀåÈ¿°ú¸¦ º¸´Ù ¿À·¡ Áö¼Ó½ÃÄÑ ÀçÇùÂøÀ²À» ÀúÇϽÃų ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ÀåºñÀÇ ±â¼ú Çõ½Å°ú °ü·ÃµÈ ³ôÀº ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ÀýÂ÷ ¹× ½ºÅÙÆ® À¯Ä¡¼ú°ú °°Àº ´ëü Ä¡·á¿ÍÀÇ ¾ö°ÝÇÑ °æÀïÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ Á¦Çѵ˴ϴÙ.ÀÌ ºÐ¾ß´Â ¶ÇÇÑ »óȯÀÇ ¹®Á¦¿Í Ä«Å×Å͸¦ ÀÌ¿ëÇÑ ÀýÂ÷¿¡ ¼÷·ÃµÈ Àü¹®°¡°¡ ÇÊ¿äÇÏ´Ù´Â °úÁ¦¿¡µµ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. À̹ÌÁö ó¸® ±â´ÉÀÇ ÅëÇÕ, ½Ç½Ã°£ Ç÷Çà µ¿Å ¸ð´ÏÅ͸µÀ»À§ÇÑ µ¥ÀÌÅÍ Æ®·£½º¹Ì¼ÇÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ½º¸¶Æ® Ä«Å×ÅÍ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. °è¼Ó ÁøÈ­ÇÏ´Â Áß¿äÇÑ ¼º°ÝÀ» º¸¿©ÁÝ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 28¾ï 2,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 30¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 45¾ï 1,000¸¸ ´Þ·¯
CAGR(%) 6.91%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â PTA dz¼± Ä«Å×ÅÍ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

PTA dz¼± Ä«Å×ÅÍ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ëÀ» ÅëÇØ º¯¸ð¸¦ °Þ°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º Áúȯ ¹× Ç÷°ü Àå¾Ö Áõ°¡
    • ½ÉÇ÷°ü°Ç°­¿¡ ´ëÇÑ Á¢±ÙÀ» È®´ëÇϱâ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í Àμ¾Æ¼ºê
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • PTA dz¼± Ä«Å×ÅÍÀÇ Á¦Ç° ȸ¼ö »ç·Ê
  • ½ÃÀå ±âȸ
    • PTA dz¼± Ä«Å×ÅÍÀÇ ±â¼úÀû Áøº¸
    • PTA dz¼± Ä«Å×ÅÍ ½ÂÀÎ ¹× Á¦Ç° Ãâ½Ã È®´ë
  • ½ÃÀåÀÇ °úÁ¦
    • PTA dz¼± Ä«Å×ÅÍ »ç¿ë¿¡ µû¸¥ ±â¼úÀû Á¦¾à°ú °Ç°­ ÇÕº´Áõ

Porter's Five Force : PTA dz¼± Ä«Å×ÅÍ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : PTA dz¼± Ä«Å×ÅÍ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº PTA dz¼± Ä«Å×ÅÍ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÕÀ¸·Î ¿¹»óÇÑ Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : PTA dz¼± Ä«Å×ÅÍ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

PTA dz¼± Ä«Å×ÅÍ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : PTA dz¼± Ä«Å×ÅÍ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â PTA dz¼± Ä«Å×ÅÍ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : PTA dz¼± Ä«Å×ÅÍ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

PTA dz¼± Ä«Å×ÅÍ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼º Áúȯ ¹× Ç÷°ü Àå¾ÖÀÇ ¹ß»ý·üÀÇ »ó½Â
      • ½ÉÀåÇ÷°ü°Ç°­¿¡ ´ëÇÑ Á¢±ÙÀ» È®´ëÇϱâ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í Àμ¾Æ¼ºê
    • ¾ïÁ¦¿äÀÎ
      • PTA dz¼± Ä«Å×ÅÍÀÇ Á¦Ç° ȸ¼ö »ç·Ê
    • ±âȸ
      • PTA dz¼± Ä«Å×ÅÍÀÇ ±â¼úÀû Áøº¸
      • PTA dz¼± Ä«Å×ÅÍ ½ÂÀÎ ¹× Á¦Ç° Ãâ½Ã È®´ë
    • °úÁ¦
      • PTA dz¼± Ä«Å×ÅÍ »ç¿ë°ú °ü·ÃµÈ ±â¼úÀû Á¦¾à°ú °Ç°­ ÇÕº´Áõ
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • ÀçÁú : ³»ºÎ½Ä¼ºÀÌ ¶Ù¾î³­ ³ªÀÏ·ÐÀÌ PTA dz¼± Ä«Å×ÅÍ¿¡ ³Î¸® ä¿ëµÇ°í ÀÖ½À´Ï´Ù.
    • À¯Åë ä³Î : ¿Â¶óÀÎ À¯Åë ä³ÎÀÇ µµÀÔ¿¡ ±â¿©ÇÏ´Â e¾à±¹ÀÇ È®´ë
    • ÀÀ¿ë : °ü»ó µ¿¸Æ ÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó PTA dz¼± Ä«Å×ÅÍ Ã¤¿ë ÇÊ¿ä
    • ÃÖÁ¾ »ç¿ëÀÚ : Àü¹® Ŭ¸®´Ð¿¡¼­ PTA dz¼± Ä«Å×ÅÍ ¼ö¿ä Áõ°¡
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå PTA dz¼± Ä«Å×ÅÍ ½ÃÀå : Àç·áº°

  • ³ªÀÏ·Ð
  • Æú¸®¿ì·¹Åº

Á¦7Àå PTA dz¼± Ä«Å×ÅÍ ½ÃÀå : À¯Åë ä³Îº°

  • ¿ÀÇÁ¶óÀÎ
  • ¿Â¶óÀÎ

Á¦8Àå PTA dz¼± Ä«Å×ÅÍ ½ÃÀå : ¿ëµµº°

  • °ü»óµ¿¸ÆÁúȯ
  • ¸»ÃÊ Ç÷°ü Áúȯ

Á¦9Àå PTA dz¼± Ä«Å×ÅÍ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • º´¿ø ¶Ç´Â Áø·á¼Ò
  • Àü¹® Ŭ¸®´Ð

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ PTA dz¼± Ä«Å×ÅÍ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ PTA dz¼± Ä«Å×ÅÍ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ PTA dz¼± Ä«Å×ÅÍ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Cordis, MedAlliance Àμö ¿Ï·á ¹ßÇ¥
    • Biotronik, LINC¿¡¼­ ¿À½ºÄ« ´Ù±â´É ¸»ÃÊ Ä«Å×Å͸¦ ¹ßÇ¥ 2023
    • BrosMed°¡ Tiche 0.035 °í¾Ð PTA dz¼± È®Àå Ä«Å×ÅÍÀÇ CE MDR ½ÂÀÎ ¹ßÇ¥
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • Accura Medizintechnik GmbH
  • Andratec GmbH
  • AV Medical Technologies Ltd.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd
  • Cardinal Health, Inc.
  • Conic Vascular
  • Cook Medical Inc.
  • Freudenberg & Co. KG
  • Infinity Angioplasty Balloon Company
  • Koninklijke Philips NV
  • Leo Medical Co.,Ltd.
  • Medcaptain Medical Technology Co., Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Nordson Corporation
  • NuMED
  • Poba Medical
  • Q3 Medical Devices Limited
  • QX Medical LLC
  • Ridgeback Technologies
  • Simeks Medical
  • Teleflex Incorporated
  • Terumo Medical Corporation
JHS 24.12.30

The PTA Balloon Catheter Market was valued at USD 2.82 billion in 2023, expected to reach USD 3.01 billion in 2024, and is projected to grow at a CAGR of 6.91%, to USD 4.51 billion by 2030.

The scope and definition of the PTA (Percutaneous Transluminal Angioplasty) Balloon Catheter market encompass devices designed to dilate constricted blood vessels or to open them up for increased blood flow, commonly employed in treating peripheral artery disease (PAD). The necessity for PTA balloon catheters arises from the rising incidences of cardiovascular diseases, obesity, and a growing aging population, which contribute to vascular complications. These catheters are applied in various medical settings, primarily hospitals and ambulatory surgical centers, with end-use extending to healthcare providers who specialize in cardiology and peripheral vascular interventions. The market is driven by technological advancements, increasing healthcare expenditures, and a growing demand for minimally invasive procedures. Key factors influencing growth include innovation in catheter design for enhanced compliance and pushability, strategic collaborations between key market players and health institutions, and an increased prevalence of lifestyle diseases. Potential opportunities within the market lie in emerging economies with improving healthcare infrastructure and untapped patient demographics. Companies should invest in research focused on developing next-generation balloon catheters with better performance features, such as drug-coated balloons ensuring longer-lasting dilation effects and reducing restenosis rates. However, market growth is limited by high costs associated with healthcare device innovations, stringent regulatory procedures, and stiff competition from alternative treatments like stenting. The sector also faces challenges with reimbursement issues and the need for highly skilled professionals for catheter-based procedures. Innovation areas include biodegradable balloons, integration of imaging capabilities for precise navigation, and smart catheters that allow data transmission for real-time hemodynamic monitoring. The PTA balloon catheter market exhibits a critical nature of ongoing evolution, characterized by continuous research and development to meet the increasing demand for efficient, cost-effective solutions in patient care.

KEY MARKET STATISTICS
Base Year [2023] USD 2.82 billion
Estimated Year [2024] USD 3.01 billion
Forecast Year [2030] USD 4.51 billion
CAGR (%) 6.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving PTA Balloon Catheter Market

The PTA Balloon Catheter Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of chronic diseases and vascular disorders
    • Government initiatives and incentives to expand access to cardiovascular healthcare
  • Market Restraints
    • Cases of product recall of PTA balloon catheters
  • Market Opportunities
    • Technological advancements in PTA balloon catheter
    • Expanding approvals and product launches of PTA balloon catheter
  • Market Challenges
    • Technical constraints and health complications associated with the use of PTA balloon catheters

Porter's Five Forces: A Strategic Tool for Navigating the PTA Balloon Catheter Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the PTA Balloon Catheter Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the PTA Balloon Catheter Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the PTA Balloon Catheter Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the PTA Balloon Catheter Market

A detailed market share analysis in the PTA Balloon Catheter Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the PTA Balloon Catheter Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the PTA Balloon Catheter Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the PTA Balloon Catheter Market

A strategic analysis of the PTA Balloon Catheter Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the PTA Balloon Catheter Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accura Medizintechnik GmbH, Andratec GmbH, AV Medical Technologies Ltd., B. Braun SE, Becton, Dickinson and Company, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, BrosMed Medical Co., Ltd, Cardinal Health, Inc., Conic Vascular, Cook Medical Inc., Freudenberg & Co. KG, Infinity Angioplasty Balloon Company, Koninklijke Philips N.V., Leo Medical Co.,Ltd., Medcaptain Medical Technology Co., Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Nordson Corporation, NuMED, Poba Medical, Q3 Medical Devices Limited, QX Medical LLC, Ridgeback Technologies, Simeks Medical, Teleflex Incorporated, and Terumo Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the PTA Balloon Catheter Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Matrerial, market is studied across Nylon and Polyurethane.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Application, market is studied across Coronary Artery Disease and Peripheral Vascular Disease.
  • Based on End-User, market is studied across Ambulatory Surgery Centers, Hospitals or Clinics, and Specialist Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of chronic diseases and vascular disorders
      • 5.1.1.2. Government initiatives and incentives to expand access to cardiovascular healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Cases of product recall of PTA balloon catheters
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in PTA balloon catheter
      • 5.1.3.2. Expanding approvals and product launches of PTA balloon catheter
    • 5.1.4. Challenges
      • 5.1.4.1. Technical constraints and health complications associated with the use of PTA balloon catheters
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Material: Widespread adoption of nylon in PTA balloon catheters due to its superior corrosion resistance
    • 5.2.2. Distribution channel: Expanding e-pharmacies contributing to the adoption of online distribution channels
    • 5.2.3. Application: Growing incidences of coronary artery disease necessitating the adoption of PTA balloon catheter
    • 5.2.4. End-user: Widening need for PTA balloon catheters in specialist clinics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. PTA Balloon Catheter Market, by Matrerial

  • 6.1. Introduction
  • 6.2. Nylon
  • 6.3. Polyurethane

7. PTA Balloon Catheter Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Offline
  • 7.3. Online

8. PTA Balloon Catheter Market, by Application

  • 8.1. Introduction
  • 8.2. Coronary Artery Disease
  • 8.3. Peripheral Vascular Disease

9. PTA Balloon Catheter Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Hospitals or Clinics
  • 9.4. Specialist Clinics

10. Americas PTA Balloon Catheter Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific PTA Balloon Catheter Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa PTA Balloon Catheter Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Cordis Announces the Completed Acquisition of MedAlliance
    • 13.3.2. Biotronik Launches Oscar Multifunctional Peripheral Catheter at LINC 2023
    • 13.3.3. BrosMed Announced CE MDR Approval of Tiche 0.035 High Pressure PTA Balloon Dilatation Catheter
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accura Medizintechnik GmbH
  • 3. Andratec GmbH
  • 4. AV Medical Technologies Ltd.
  • 5. B. Braun SE
  • 6. Becton, Dickinson and Company
  • 7. Biosensors International Group, Ltd.
  • 8. BIOTRONIK SE & Co. KG
  • 9. Boston Scientific Corporation
  • 10. BrosMed Medical Co., Ltd
  • 11. Cardinal Health, Inc.
  • 12. Conic Vascular
  • 13. Cook Medical Inc.
  • 14. Freudenberg & Co. KG
  • 15. Infinity Angioplasty Balloon Company
  • 16. Koninklijke Philips N.V.
  • 17. Leo Medical Co.,Ltd.
  • 18. Medcaptain Medical Technology Co., Ltd.
  • 19. Medtronic PLC
  • 20. Meril Life Sciences Pvt. Ltd.
  • 21. MicroPort Scientific Corporation
  • 22. Nordson Corporation
  • 23. NuMED
  • 24. Poba Medical
  • 25. Q3 Medical Devices Limited
  • 26. QX Medical LLC
  • 27. Ridgeback Technologies
  • 28. Simeks Medical
  • 29. Teleflex Incorporated
  • 30. Terumo Medical Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦